Hiring?
Logo

Patented AntiVirus Agent

location_on

Singapore, Singapore

Short Summary

Our Patented Antimicrobial Agent, trademarked Rozinco, protects all surfaces with a residual effect that prevents the growth of microbes. Rozinco is a self-powered, powder sized micro-factory that emits oxidising agents which kill microbes.

Overview

Target
US$1,000,000
Minimum
US$14,000
Investment Raised
US$350,000
Previous Rounds US$350,000
Stage MVP/Finished Product
Investor Role

Highlights

  • Owns a worldwide patented antibacterial, antifungal, antiviral technology
  • Many products ready for commercialization to meet COVID protection demand
  • Generating revenue since 2019
  • Rozinco has several verifications on the efficacy
  • Already raised S$500k+
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
31% raised

MyCLNQ-Health(Video/Tele)

location_on Singapore, Singapore

MyCLNQ-"Connecting all your Healthcare needs" (betterment of community) MyCLNQ has full suite of Tele Health (Video/Tele/House call/Chat); Medical Transport booking; Digital booking for Medical caregiver (Escort/Companion/Nursing) and Home Therapy.

US$ 570,000

Target

US$ 71,000

Min per Investor

0% raised

Trialcome

location_on Singapore,

Trialcome is a patient-centred Medication Adherence service aiming to seamlessly integrate the process of medication(s) intake recording into the patient's normal behaviour patterns both in clinical trials settings and in general clinical practice.

US$ 120,000

Target

US$ 17,000

Min per Investor

Global Pro
88% raised

Nocira Migraine Device

location_on South West, USA

Nocira migraine device: pain relief via gentle ear pressure changes = far more effective vs current drugs/devices, safe, consumer-friendly, easy/pleasant to use; 4 trials, 100+ patients; 150+yrs experienced leaders; major KOL champions; $8+M raised

US$ 9,000,000

Target

US$ 10,000

Min per Investor

load one similar proposal